Milton H. Grannatt
Director/Board Member at Myopharm Ltd.
Milton H. Grannatt active positions
| Companies | Position | Start | End |
|---|---|---|---|
Myopharm Ltd.
 Myopharm Ltd. BiotechnologyHealth Technology Myopharm Ltd. develops and produces nutrition specifically for individuals with type 2 diabetes. The Australian company was founded in 2020 and the CEO is Karinza Phoenix. | Director/Board Member | - | - |
Career history of Milton H. Grannatt
Former positions of Milton H. Grannatt
| Companies | Position | Start | End |
|---|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Director/Board Member | 01/03/2013 | - |
Training of Milton H. Grannatt
| Lehigh University | Doctorate Degree |
Statistics
International
| Japan | 2 |
| United States | 2 |
| Australia | 2 |
Operational
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Myopharm Ltd.
Myopharm Ltd. BiotechnologyHealth Technology Myopharm Ltd. develops and produces nutrition specifically for individuals with type 2 diabetes. The Australian company was founded in 2020 and the CEO is Karinza Phoenix. | Health Technology |
- Stock Market
- Insiders
- Milton H. Grannatt
- Experience
